• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Europe Safety Lancet Market Analysis

    ID: MRFR/MED/0156-HCR
    110 Pages
    Kinjoll Dey
    September 2025

    Europe, Middle East & Africa Safety Lancet Market Research Report Information by Type (Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet), by End User (Hospitals & Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Others), and By Region (Europe, and Middle East & Africa) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Europe Safety Lancet Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Analysis

    In-depth Analysis of Europe Safety Lancet Market Industry Landscape

    The Safety Lancet Market in Europe, the Middle East, and Africa (EMEA) is encountering critical growth, driven by the rising emphasis on blood safety in healthcare rehearses. As awareness of bloodborne diseases rises, the demand for safety lancets as a more secure and more helpful alternative for blood collection is developing across the district. The predominance of constant illnesses, like diabetes and cardiovascular conditions, is a key variable impacting the safety lancet market in EMEA. Patients with persistent illnesses frequently require incessant blood testing, and safety lancets offer a dependable and easy to use answer for healthcare experts and patients the same. Continuous developments in safety lancet innovation are forming market elements. The advancement of lancets with features like a single prick activation, flexible penetration acuity, and automatic withdrawal is upgrading client experience, making blood collection more effective and less painful. The rising pattern of home healthcare is impacting market elements, with safety lancets being embraced for at-home blood collection. Patients are progressively dealing with their health at home, and safety lancets give a viable answer for self-checking, adding to market growth. Rigid regulatory standards with respect to blood collection practices and patient safety are molding the safety lancet market in EMEA. Adherence to regulatory prerequisites is fundamental for makers to guarantee the safety and viability of their items, cultivating trust among healthcare experts. The variety in healthcare framework across the EMEA district impacts the reception and utilization patterns of safety lancets. Variations in healthcare frameworks and practices add to a powerful market landscape, with a requirement for versatile and versatile arrangements.

    Market Summary

    The Europe, The Middle East and Africa Safety Lancet market is projected to grow significantly from 1.8 USD Billion in 2024 to 3.7 USD Billion by 2035.

    Key Market Trends & Highlights

    Europe, The Middle East & Africa Safety Lancet Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate (CAGR) of 6.76% from 2025 to 2035. By 2035, the market valuation is anticipated to reach 3.7 USD Billion, indicating robust growth potential. In 2024, the market is valued at 1.8 USD Billion, laying a strong foundation for future expansion. Growing adoption of safety technologies due to increasing regulatory compliance is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.8 (USD Billion)
    2035 Market Size 3.7 (USD Billion)
    CAGR (2025-2035) 6.76%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Becton Dickinson and Company, Bayer AG, Terumo Corporation, HTL-STREFA, Sarstedt AG &amp; Co., Accu-Chek (Roche), B Braun Melsungen Ag, Hoffmann-La Roche Ltd., Ypsomed Holding, Greiner Bio-One International Gmbh, Owen Mumford, Abbott</p>

    Market Trends

    Increasing incidences of diabetes

    The increasing incidences of diabetes worldwide are driving the growth of the safety lancet market. Safety lancets are used for blood glucose monitoring and medication administration in diabetic patients. As the prevalence of diabetes continues to rise, the demand for safety lancets is also increasing. Additionally, the growing awareness about the importance of regular monitoring of blood glucose levels in diabetic patients is contributing to the growth of the safety lancet market. Regular blood glucose monitoring is essential for managing diabetes and preventing complications, leading to a higher adoption of safety lancets among diabetic patients.

    For instance, according to the British Diabetic Association, about 73 million were diagnosed with diabetes in 2021, and 27 million adults were undiagnosed.

    Moreover, advancements in technology have led to the development of safer and more user-friendly safety lancets, further fueling the growth of the market. These innovative products offer improved comfort and convenience for patients, encouraging more individuals to use safety lancets for blood glucose monitoring. Overall, the increasing prevalence of diabetes, rising awareness about the importance of blood glucose monitoring, and technological advancements in safety lancets are driving the growth of the safety lancet market.

    Europe Safety Lancet Market Market Drivers

    Market Segment Insights

    Europe, The Middle East & Africa Safety Lancet Type Insights

    <p>The Europe, The Middle East &amp; Africa Safety Lancet market segmentation, based on type, includes Push Button Safety Lancet, Pressure Activated Safety Lancet and Side Button Safety Lancet. The Push Button Safety Lancet segment dominated the market in the base year, i.e., 2023, and is the fastest-growing segment during the forecast period, 2024–2032. This is due to the increased safety, and push-button mechanism often delivers a faster and more precise puncture, which some users find less painful than using a traditional lancet.</p>

    Europe, The Middle East & Africa Safety Lancet End User Insights

    <p>The Europe, The Middle East &amp; Africa Safety Lancet market is segmented, based on end user, into Hospitals &amp; Clinics, Diagnostic Centers and Pathology Laboratories, Home Diagnostics and Others. The Hospitals &amp; Clinics segment held the majority of the market and is the fastest-growing segment during the forecast year due to the growing demand for frequent glucose testing, hemoglobin testing, cholesterol testing, allergy testing, coagulation testing, and neonatal screening across the region is driving the growth of market.</p>

    <p>FIGURE 2: Europe, The Middle East &amp; Africa Safety Lancet, By End User, 2023 &amp; 2032 (USD Billion)</p>

    <p>Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review</p>

    Get more detailed insights about Europe, Middle East and Africa Safety Lancet Market Research Report – Forecast to 2032

    Regional Insights

    By region, the study segments the market into Europe, and Middle East. In Safety Lancet market Europe held the largest market share in 2023 due to the increasing adoption of Safety Lancets in healthcare facilities and rising awareness about preventing needle-stick injuries among healthcare professionals. Additionally, the stringent regulatory guidelines pertaining to the safe disposal of medical waste have also contributed to the dominance of the Safety Lancet market in Europe. The market is expected to witness significant growth in the coming years, driven by increasing healthcare expenditure and technological advancements in Safety Lancet devices.

    FIGURE 3: Europe, The Middle East & Africa Safety Lancet , By Region, 2022 & 2032 (USD Billion)

    EUROPE, THE MIDDLE EAST & AFRICA SAFETY LANCET MARKET, BY REGION

    Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

    The Middle East & Africa Safety Lancet market accounted for the second-largest market share the increasing prevalence of chronic diseases such as diabetes, which require regular blood glucose monitoring. Additionally, Countries in the Middle East & Africa region, such as the UAE, Saudi Arabia, and South Africa, are focusing on improving their healthcare infrastructure and promoting the use of safety devices to enhance patient and healthcare worker safety. This, in turn, is expected to drive the demand for safety lancets in the region.

    Furthermore, increasing healthcare expenditures, growing geriatric population, and rising demand for point-of-care testing are also expected to fuel market growth in the Middle East & Africa region. With advancements in technology and the development of innovative safety lancet products, the market is expected to continue to expand in the coming years.

    Key Players and Competitive Insights

    Some of the key market players in the Eu, Middle East & Africa safety lancet market include Becton Dickinson and Company, Bayer AG, Terumo Corporation, HTL-STREFA, Sarstedt AG & Co., and Accu-Chek (Roche). These companies are continuously investing in research and development to develop innovative products and expand their product portfolio. They are also focusing on strategic collaborations, partnerships, and acquisitions to strengthen their market position and expand their geographic presence.

    Competition in the safety lancet market is intense, with companies striving to differentiate their products through features such as ergonomic design, ease of use, and increased safety measures. In addition, there is a growing trend towards the development of technologically advanced safety lancets that provide improved comfort and reduced pain for patients.

    Key Companies in the Europe Safety Lancet Market market include

    Industry Developments

    Future Outlook

    Europe Safety Lancet Market Future Outlook

    Market Segmentation

    Europe, The Middle East & Africa Safety Lancet Type Outlook

    • Push Button Safety Lancet
    • Pressure Activated Safety Lancet
    • Side Button Safety Lancet

    Europe, The Middle East & Africa Safety Lancet End User Outlook

    • Hospitals & Clinics
    • Diagnostic Centers and Pathology Laboratories
    • Home Diagnostics
    • Others

    Europe, The Middle East & Africa Safety Lancet Regional Outlook

    • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • Middle East

    Report Scope

    Report Attribute/MetricDetails
    Market Size 2023USD 1.5 billion
    Market Size 2024USD 1.8 billion
    Market Size 2032USD 3.0 billion
    Compound Annual Growth Rate (CAGR)7.22% (2024-2032)
    Base Year2023
    Forecast Period2024-2032
    Historical Data2019 to 2022
    Forecast UnitsValue (USD Billion)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments CoveredType, End User, and Region
    Geographies CoveredEurope, Middle East & Africa
    Countries CoveredGermany, France, the UK, Italy, Spain, Middle East & Africa
    Key Companies ProfiledB Braun Melsungen AG, F. Hoffmann-La Roche Ltd, Ypsomed Holding, Becton, Dickinson and Company, Terumo Corporation, Greiner Bio-One International Gmbh, Owen Mumford, Abbott, Sarstedt Ag & Co. Kg, and Htl-Strefa, Inc.
    Key Market OpportunitiesTechnological advancements
    Key Market DriversRising incidences of diabetes Growing prevalence of obesity

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    How much is the Europe, The Middle East & Africa Safety Lancet market?

    The Europe, The Middle East &amp; Africa Safety Lancet market is anticipated to reach 3.0 billion at a CAGR of 22% during the forecast period of 2024-2032.

    How big is the US Safety Lancet market?

    The Germany held the largest market with a 65-75% share of the Europe market for Safety Lancet market in 2023.

    What is the growth rate of the Europe, The Middle East & Africa Safety Lancet market?

    The Europe, The Middle East &amp; Africa Safety Lancet market is expected to grow at 22% CAGR during the forecast period from 2024 to 2032.

    Which region held the largest market share in 2022 in the Europe, The Middle East & Africa Safety Lancet market?

    The Europe region market held the largest market share in 2022 in the Europe, The Middle East &amp; Africa Safety Lancet market.

    Who are the key players in the Europe, The Middle East & Africa Safety Lancet market?

    The key players include B Braun Melsungen AG, F. Hoffmann-La Roche Ltd, Ypsomed Holding, Becton, Dickinson and Company, Terumo Corporation, Greiner Bio-One International Gmbh, Owen Mumford, Abbott, Sarstedt Ag &amp; Co. Kg, and Htl-Strefa, Inc., and others.

    1. --- |-1 Introduction1.1 Definition1.2 Scope of the Study1.2.1 Research Objectives1.2.2 Assumptions & Limitations1.3 Market Structure2 Research Methodology2.1 Research Process2.2 Primary Research2.3 Secondary Research2.4 Forecast Model3 Report Excerpt4 Forecast Indicators4.1 Introduction4.2 Growth Drivers4.3 Growth Barriers4.4 Growth Opportunities4.5 Macroecnomical Indicators5 Market Analysis6 Europe, the Middle East And Africa Safety Lancet Market, By Usage6.1 Introduction6.2 Lancets for Pediatric  6.3 Lancets for Adults7 Europe, the Middle East And Africa Safety Lancet Market, By Gauge7.1 Introduction7.2 17/18g7.3 21g7.4 23g7.5 25g7.6 28g7.7 30g7.8 Others8 Europe, the Middle East And Africa Safety Lancet Market, By Penetration Depth8.1 Introduction8.2 0.8 Mm to 1.0 Mm8.3 1.1 Mm to 1.5 Mm8.4 1.6 Mm to 2.0 Mm8.5 2.1 Mm to 2.5 Mm8.6 2.5 Mm to 3.0 Mm8.7 Others9 Geographical Exploration9.1 Introduction9.2 Europe9.2.1 Germany9.2.2 France9.2.3 U.K.9.2.4 Italy9.2.5 Spain9.2.6 Rest of Europe9.3 Middle East & Africa 10 Competitive Analysis10.1 Introduction10.2 Market Share10.3 Competitive/Strategic Scenario11 Company Profiles11.1 Introduction11.2 Accriva Diagnostics11.3 Becton, Dickinson And Company11.4 Dynarex11.5 Europe, the Middle East And Africa Medical Market Corporation (Gmmc)11.6 Htl-Strefa, Inc11.7 Jsb Healthcare11.8 Kabe Labortechnik11.9 Med Trust11.1 Medical Plastic Devices Inc.11.12 Medicore11.13 Medipurpose Private Limited11.14 Medline Industries, Inc.11.15 Ningbo Medsun Medical Co., Ltd.11.16 Nipro Diagnostics, Inc.11.17 Owen Mumford Ltd.10.18 Prima Lab Sa10.19 Smiths Medical10.2 Xuzhou Kejian Hi-Tech Co.,Ltd.12 Appendix12.1 Discussion Blue Print12.2 Industry Expert Quotes12.3 Bibliography

    Europe, Middle East and Africa Safety Lancet Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials